3i Invests In Leading Xylitol Manufacturer
This article was originally published in PharmAsia News
Executive Summary
3i, the world's leading company in private equity and venture capital, announced that it will invest in Chinese firm Futian Pharmaceutical and become a minority shareholder. 3i did not disclose details about the investment. Futian, based in Yu City, Shandong Province, is a major xylitol manufacturer with many international customers. 3i's investment in Futian will inject capital and strengthen the latter's management team to further help establish its global position and bring new expansion opportunities. (Click here for more - Chinese Language)